mRNA-4157,Pembrolizumab
Moderna,Merck
['mrna-4157', 'moderna']
dr. matteo s. carlino will be presenting his abstract on phase 2 data for mrna-4157 (v940), an investigational #mrna individualized neoantigen therapy, at the 2023 annual meeting today. join him for the poster discussion session s406 at 4:30 pm cdt today! 
Our mission is to deliver the greatest possible impact to people through mRNA medicines.